GGrantIndex
Sort

40,608 grants matching prostate cancer

PET-determined prostate brachytherapy dosing using intraoperative image-guidance

$532,313
Daniel Song · Johns Hopkins University · R01 · FY2017 · CA

Racially-associated MRI analysis and modeling for predicting aggressive prostate cancer

$532,300
Kyung Hyun Sung · University Of California Los Angeles · R01 · FY2024 · CA

Diazeniumdiolates as Broad-Spectrum Anticancer Agents

$532,298
Larry K Keefer · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Prostate Cancer Prevention by n-3 Unsaturated Fatty Acids

$532,290
Jose A Halperin · Harvard Medical School · R01 · FY2006 · CA

IDENTIFYING GENOME CHANGES IN CANCER DEVELOPMENT

$532,214
Weill Medical College Of Cornell Univ · R01 · FY2000 · CA

Quality Control in Ribosome Assembly - the Function of Regulatory Proteins

$532,086
Katrin Karbstein · Scripps Florida · R01 · FY2019 · GM

Quality Control in Ribosome Assembly - the Function of Regulatory Proteins

$532,086
Katrin Karbstein · Scripps Florida · R01 · FY2018 · GM

A FAP-Activated Proteasome Inhibitor for Killing Solid Tumors

$532,072
Barry Jones · Arisaph Pharmaceuticals, Inc. · R42 · FY2015 · CA

Leveraging cross-cancer shared heritability to better understand the genetic architecture of cancer

$531,968
Sara Lindstroem · University Of Washington · R01 · FY2021 · CA

MicroRNAs in the Progression and Metastisis of Prostate Cancer

$531,947
Rajvir Dahiya · University Of California, San Francisco · R01 · FY2011 · CA

Computational Methods for Identifying Non-coding Cancer Drivers

$531,893
Ekta Khurana · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · CA

Research Infrastructure Core

$531,887
Valerie Odero-Marah · Clark Atlanta University · U54 · FY2023 · MD

Whitlockite nanoparticle-based immunotherapy for bone metastasis

$531,867
Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2023 · CA

Whitlockite nanoparticle-based immunotherapy for bone metastasis

$531,867
Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2022 · CA

Radiation, Hormones &Antisense Prostate Cancer Therapy

$531,840
Fox Chase Cancer Center · R01 · FY2003 · CA

Molecular analysis of castration sensitivity in the prostate epithelium

$531,825
Michael M. Shen · Columbia University Health Sciences · R01 · FY2025 · CA

HIV induced anti-cancer HERV immunity in prostate, breast and colon cancers

$531,650
Douglas F Nixon · George Washington University · R01 · FY2016 · CA

Inhibitors of protein-protein interactions

$531,607
Nadya Tarasova · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Prostate Cancer Prevention by n-3 Unsaturated Fatty Acids

$531,601
Jose A Halperin · Harvard Medical School · R01 · FY2007 · CA

Addressing Misinformation to Promote Equity in Prostate Cancer Care

$531,583
Stacy Loeb · New York University School Of Medicine · R01 · FY2024 · CA

Biospecimen Acquisition, Processing and Classification Unit

$531,549
Christine A Iacobuzio-Donahue · Sloan-Kettering Inst Can Research · U2C · FY2019 · CA

Role of p62 in metabolic reprograming of the tumor stroma in prostate cancer

$531,494
Maria Teresa Diaz Meco Conde · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · CA

Career Development in Pediatric and Medical Oncology

$531,466
Irwin Bernstein · Fred Hutchinson Cancer Research Center · K12 · FY2016 · CA

The Evaluation of Novel Therapeutics for Genitourinary Malignancies

$531,416
William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA

Image Biomarker Development for TreatmentEfficacy of Prostate Cancer to the Bone

$531,387
Brian D. Ross · University Of Michigan At Ann Arbor · R01 · FY2009 · CA